KEGG   PATHWAY: nle04310
Entry
nle04310                    Pathway                                
Name
Wnt signaling pathway - Nomascus leucogenys (northern white-cheeked gibbon)
Description
Wnt proteins are secreted morphogens that are required for basic developmental processes, such as cell-fate specification, progenitor-cell proliferation and the control of asymmetric cell division, in many different species and organs. There are at least three different Wnt pathways: the canonical pathway, the planar cell polarity (PCP) pathway and the Wnt/Ca2+ pathway. In the canonical Wnt pathway, the major effect of Wnt ligand binding to its receptor is the stabilization of cytoplasmic beta-catenin through inhibition of the bea-catenin degradation complex. Beta-catenin is then free to enter the nucleus and activate Wnt-regulated genes through its interaction with TCF (T-cell factor) family transcription factors and concomitant recruitment of coactivators. Planar cell polarity (PCP) signaling leads to the activation of the small GTPases RHOA (RAS homologue gene-family member A) and RAC1, which activate the stress kinase JNK (Jun N-terminal kinase) and ROCK (RHO-associated coiled-coil-containing protein kinase 1) and leads to remodelling of the cytoskeleton and changes in cell adhesion and motility. WNT-Ca2+ signalling is mediated through G proteins and phospholipases and leads to transient increases in cytoplasmic free calcium that subsequently activate the kinase PKC (protein kinase C) and CAMKII (calcium calmodulin mediated kinase II) and the phosphatase calcineurin.
Class
Environmental Information Processing; Signal transduction
Pathway map
nle04310  Wnt signaling pathway
nle04310

Other DBs
GO: 0016055
Organism
Nomascus leucogenys (northern white-cheeked gibbon) [GN:nle]
Gene
100594546  PORCN; protein-serine O-palmitoleoyltransferase porcupine isoform X6 [KO:K00181] [EC:2.3.1.250]
100587307  WNT1; proto-oncogene Wnt-1 [KO:K03209]
100607954  WNT2B; protein Wnt-2b isoform X2 [KO:K00182]
100600353  WNT2; protein Wnt-2 [KO:K00182]
100606846  WNT3A; protein Wnt-3a isoform X2 [KO:K00312]
100599381  WNT3; proto-oncogene Wnt-3 [KO:K00312]
100604353  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
100602014  WNT5A; protein Wnt-5a [KO:K00444]
100596686  WNT5B; protein Wnt-5b [KO:K00444]
100606818  WNT6; protein Wnt-6 [KO:K00445]
100579580  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
100593900  WNT7A; protein Wnt-7a [KO:K00572]
100586052  WNT8A; protein Wnt-8a isoform X2 [KO:K00714]
100603238  WNT8B; protein Wnt-8b [KO:K00714]
100606502  WNT9A; protein Wnt-9a [KO:K01064]
100602760  WNT9B; protein Wnt-9b isoform X1 [KO:K01064]
100607164  WNT10A; protein Wnt-10a [KO:K01357]
100587640  WNT10B; protein Wnt-10b [KO:K01357]
100594864  WNT11; protein Wnt-11 [KO:K01384]
100605294  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
100587019  CER1; cerberus [KO:K01645]
100596028  NOTUM; palmitoleoyl-protein carboxylesterase NOTUM [KO:K19882] [EC:3.1.1.98]
100595695  WIF1; wnt inhibitory factor 1 [KO:K01691]
100590543  SOST; sclerostin [KO:K16834]
100598275  DKK1; dickkopf-related protein 1 [KO:K02165]
100595348  DKK2; dickkopf-related protein 2 [KO:K02165]
100589069  DKK4; dickkopf-related protein 4 [KO:K02165]
100580793  SERPINF1; pigment epithelium-derived factor isoform X1 [KO:K19614]
100582389  SFRP1; secreted frizzled-related protein 1 [KO:K02166]
100605388  SFRP2; secreted frizzled-related protein 2 [KO:K02176]
100579183  FRZB; secreted frizzled-related protein 3 [KO:K25481]
100592334  SFRP4; secreted frizzled-related protein 4 [KO:K02185]
100594866  SFRP5; secreted frizzled-related protein 5 [KO:K02222]
100596563  RSPO1; R-spondin-1 isoform X2 [KO:K19471]
100582311  RSPO2; R-spondin-2 [KO:K23097]
100590004  RSPO3; R-spondin-3 [KO:K23098]
115837981  RSPO4; R-spondin-4 isoform X1 [KO:K23099]
100586088  LGR4; leucine-rich repeat-containing G-protein coupled receptor 4 [KO:K04309]
100585327  LGR5; leucine-rich repeat-containing G-protein coupled receptor 5 isoform X1 [KO:K04308]
100591871  LGR6; leucine-rich repeat-containing G-protein coupled receptor 6 [KO:K08399]
100606931  RNF43; E3 ubiquitin-protein ligase RNF43 isoform X1 [KO:K15694] [EC:2.3.2.27]
100594544  ZNRF3; E3 ubiquitin-protein ligase ZNRF3 [KO:K16273] [EC:2.3.2.27]
100597685  FZD7; frizzled-7 [KO:K02432]
100605346  FZD1; frizzled-1 [KO:K02432]
100580071  FZD2; frizzled-2 [KO:K02235]
100589994  FZD3; frizzled-3 [KO:K02329]
100588311  FZD4; frizzled-4 [KO:K02354]
100589091  FZD5; frizzled-5 [KO:K02375]
100593717  FZD8; frizzled-8 [KO:K02375]
100603705  FZD6; frizzled-6 [KO:K02376]
100607762  FZD10; frizzled-10 [KO:K02842]
100592375  FZD9; frizzled-9 [KO:K02842]
100586389  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
100588313  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
100606459  BAMBI; BMP and activin membrane-bound inhibitor homolog isoform X3 [KO:K10162]
100603521  APCDD1; protein APCDD1 [KO:K25812]
100601342  APCDD1L; protein APCDD1-like [KO:K25812]
100607246  casein kinase I isoform X1 [KO:K08960] [EC:2.7.11.1]
100588242  protein Daple [KO:K25811]
100585595  DVL2; segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
100583216  DVL3; segment polarity protein dishevelled homolog DVL-3 [KO:K02353]
100593186  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
115834222  FRAT1; proto-oncogene FRAT1 [KO:K03069]
100584425  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
100588149  CSNK2A2; casein kinase II subunit alpha' [KO:K03097] [EC:2.7.11.1]
100602220  CSNK2A1; casein kinase II subunit alpha [KO:K03097] [EC:2.7.11.1]
100589867  CSNK2B; casein kinase II subunit beta [KO:K03115]
100589602  NKD1; protein naked cuticle homolog 1 [KO:K03213]
100595277  NKD2; protein naked cuticle homolog 2 [KO:K03213]
100605165  CXXC4; CXXC-type zinc finger protein 4 [KO:K03344]
100589444  SENP2; sentrin-specific protease 2 [KO:K03345] [EC:3.4.22.68]
100606885  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
100583002  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
101179424  AXIN1; axin-1 isoform X1 [KO:K02157]
100589482  AXIN2; axin-2 isoform X1 [KO:K04385]
100602025  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
100585467  APC; adenomatous polyposis coli protein isoform X3 [KO:K02085]
100595404  CSNK1A1; casein kinase I isoform X3 [KO:K08957] [EC:2.7.11.1]
100585848  CSNK1A1L; casein kinase I [KO:K08957] [EC:2.7.11.1]
100595737  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
100601518  TCF7L1; transcription factor 7-like 1 [KO:K04490]
100605701  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
100593051  LEF1; lymphoid enhancer-binding factor 1 isoform X3 [KO:K04492]
100579531  LZTS2; leucine zipper putative tumor suppressor 2 [KO:K26471]
100581521  CTNNBIP1; beta-catenin-interacting protein 1 isoform X1 [KO:K04493]
100581485  CBY1; protein chibby homolog 1 isoform X1 [KO:K23402]
100595705  CHD8; chromodomain-helicase-DNA-binding protein 8 isoform X1 [KO:K04494] [EC:5.6.2.-]
100588679  MCC; colorectal mutant cancer protein [KO:K26734]
100599167  CCAR2; cell cycle and apoptosis regulator protein 2 isoform X2 [KO:K25816]
100605499  SIRT1; NAD-dependent protein deacetylase sirtuin-1 isoform X1 [KO:K11411] [EC:2.3.1.286]
100591356  SOX17; transcription factor SOX-17 [KO:K04495]
100601461  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
100603170  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
100582932  TLE7; transducin-like enhancer protein 7 [KO:K04497]
100583788  TLE6; transducin-like enhancer protein 6 isoform X1 [KO:K04497]
100584117  TLE2; transducin-like enhancer protein 2 isoform X1 [KO:K04497]
100587624  transducin-like enhancer protein 4 isoform X1 [KO:K04497]
100595295  TLE3; transducin-like enhancer protein 3 isoform X7 [KO:K04497]
100596653  TLE1; transducin-like enhancer protein 1 isoform X1 [KO:K04497]
100581918  CTNND2; catenin delta-2 isoform X3 [KO:K23491]
100589381  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
100596998  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
100604303  RUVBL1; ruvB-like 1 [KO:K04499] [EC:5.6.2.4]
100599586  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
100583279  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
100596471  MAP3K7; mitogen-activated protein kinase kinase kinase 7 isoform X1 [KO:K04427] [EC:2.7.11.25]
100593981  NLK; serine/threonine-protein kinase NLK isoform X1 [KO:K04468] [EC:2.7.11.24]
100589322  MYC; myc proto-oncogene protein [KO:K04377]
100586501  JUN; transcription factor AP-1 [KO:K04448]
100592249  FOSL1; fos-related antigen 1 [KO:K04502]
100605736  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
100585770  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
100580170  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
100595675  CCN4; WNT1-inducible-signaling pathway protein 1 isoform X3 [KO:K22471]
100584681  PPARD; peroxisome proliferator-activated receptor delta [KO:K04504]
100581294  MMP7; matrilysin [KO:K01397] [EC:3.4.24.23]
100586383  PSEN1; presenilin-1 isoform X1 [KO:K04505] [EC:3.4.23.-]
100583577  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X8 [KO:K04345] [EC:2.7.11.11]
100579779  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
100607741  PRKACG; LOW QUALITY PROTEIN: cAMP-dependent protein kinase catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
100583326  TP53; cellular tumor antigen p53 [KO:K04451]
100583599  SIAH1; E3 ubiquitin-protein ligase SIAH1 isoform X2 [KO:K04506] [EC:2.3.2.27]
100595196  E3 ubiquitin-protein ligase SIAH1-like [KO:K04506] [EC:2.3.2.27]
100605397  CACYBP; calcyclin-binding protein isoform X1 [KO:K04507]
100596865  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
100583434  TBL1XR1; F-box-like/WD repeat-containing protein TBL1XR1 isoform X1 [KO:K04508]
100606202  TBL1X; F-box-like/WD repeat-containing protein TBL1X [KO:K04508]
100605260  FBXW11; F-box/WD repeat-containing protein 11 isoform X7 [KO:K03362]
100583099  BTRC; F-box/WD repeat-containing protein 1A isoform X1 [KO:K03362]
100580180  CUL1; cullin-1 isoform X1 [KO:K03347]
100596079  RBX1; E3 ubiquitin-protein ligase RBX1 isoform X1 [KO:K03868] [EC:2.3.2.32]
100591343  GPC4; glypican-4 [KO:K08110]
100598117  ROR1; inactive tyrosine-protein kinase transmembrane receptor ROR1 [KO:K05122] [EC:2.7.10.1]
100587820  ROR2; tyrosine-protein kinase transmembrane receptor ROR2 isoform X1 [KO:K05123] [EC:2.7.10.1]
100591428  RYK; tyrosine-protein kinase RYK isoform X1 [KO:K05128] [EC:2.7.10.1]
100595061  VANGL1; vang-like protein 1 isoform X1 [KO:K04510]
100597156  VANGL2; vang-like protein 2 [KO:K04510]
100588771  PRICKLE2; prickle-like protein 2 [KO:K04511]
100605904  PRICKLE1; prickle-like protein 1 [KO:K04511]
105737522  PRICKLE4; prickle-like protein 4 [KO:K04511]
100590141  PRICKLE3; prickle planar cell polarity protein 3 [KO:K04511]
100594079  INVS; inversin isoform X1 [KO:K19626]
100607357  DAAM1; disheveled-associated activator of morphogenesis 1 isoform X1 [KO:K04512]
100594446  DAAM2; disheveled-associated activator of morphogenesis 2 isoform X1 [KO:K04512]
100607291  RHOA; transforming protein RhoA [KO:K04513]
100585294  ROCK2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.1]
100604516  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
100598232  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
100602123  RAC3; ras-related C3 botulinum toxin substrate 3 isoform X3 [KO:K07861]
100581677  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
100605285  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
100602081  MAPK10; mitogen-activated protein kinase 10 isoform X2 [KO:K04440] [EC:2.7.11.24]
100597115  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
100600507  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X3 [KO:K05858] [EC:3.1.4.11]
100606558  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
100600865  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
100597007  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
100600165  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
100591995  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
100580290  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X30 [KO:K04515] [EC:2.7.11.17]
100598029  PPP3CC; serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
100607264  PPP3CB; serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
100583664  PPP3CA; serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1 [KO:K04348] [EC:3.1.3.16]
100600788  PPP3R2; calcineurin subunit B type 2 [KO:K06268]
100593195  PPP3R1; calcineurin subunit B type 1 [KO:K06268]
100591651  PRKCA; protein kinase C alpha type isoform X1 [KO:K02677] [EC:2.7.11.13]
100590939  PRKCB; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
100601464  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
100598995  NFATC1; nuclear factor of activated T-cells, cytoplasmic 1 isoform X1 [KO:K04446]
100599959  NFATC2; nuclear factor of activated T-cells, cytoplasmic 2 isoform X1 [KO:K17332]
100605649  NFATC3; nuclear factor of activated T-cells, cytoplasmic 3 isoform X1 [KO:K17333]
100603627  NFATC4; nuclear factor of activated T-cells, cytoplasmic 4 isoform X1 [KO:K17334]
Compound
C00076  Calcium cation
Reference
  Authors
Hatsell S, Rowlands T, Hiremath M, Cowin P.
  Title
Beta-catenin and Tcfs in mammary development and cancer.
  Journal
J Mammary Gland Biol Neoplasia 8:145-58 (2003)
DOI:10.1023/A:1025944723047
Reference
  Authors
Yang Y.
  Title
Wnts and wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis.
  Journal
Birth Defects Res Part C Embryo Today 69:305-17 (2003)
DOI:10.1002/bdrc.10026
Reference
  Authors
Kalderon D.
  Title
Similarities between the Hedgehog and Wnt signaling pathways.
  Journal
Trends Cell Biol 12:523-31 (2002)
DOI:10.1016/S0962-8924(02)02388-7
Reference
  Authors
Nusse R.
  Title
Wnts and Hedgehogs: lipid-modified proteins and similarities in signaling mechanisms at the cell surface.
  Journal
Development 130:5297-305 (2003)
DOI:10.1242/dev.00821
Reference
  Authors
Jope RS, Johnson GV.
  Title
The glamour and gloom of glycogen synthase kinase-3.
  Journal
Trends Biochem Sci 29:95-102 (2004)
DOI:10.1016/j.tibs.2003.12.004
Reference
  Authors
Veeman MT, Axelrod JD, Moon RT.
  Title
A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling.
  Journal
Dev Cell 5:367-77 (2003)
DOI:10.1016/S1534-5807(03)00266-1
Reference
  Authors
Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT.
  Title
PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling.
  Journal
Nat Cell Biol 3:628-36 (2001)
DOI:10.1038/35083016
Reference
  Authors
Saito-Diaz K, Chen TW, Wang X, Thorne CA, Wallace HA, Page-McCaw A, Lee E
  Title
The way Wnt works: Components and mechanism.
  Journal
Growth Factors 31:1-31 (2013)
DOI:10.3109/08977194.2012.752737
Reference
  Authors
Carethers JM
  Title
Intersection of transforming growth factor-beta and Wnt signaling pathways in colorectal cancer and metastasis.
  Journal
Gastroenterology 137:33-6 (2009)
DOI:10.1053/j.gastro.2009.05.011
Reference
  Authors
Lin Z, Gao C, Ning Y, He X, Wu W, Chen YG
  Title
The pseudoreceptor BMP and activin membrane-bound inhibitor positively modulates Wnt/beta-catenin signaling.
  Journal
J Biol Chem 283:33053-8 (2008)
DOI:10.1074/jbc.M804039200
Reference
  Authors
Niehrs C
  Title
The complex world of WNT receptor signalling.
  Journal
Nat Rev Mol Cell Biol 13:767-79 (2012)
DOI:10.1038/nrm3470
Reference
  Authors
Abou Ziki MD, Mani A
  Title
Wnt signaling, a novel pathway regulating blood pressure? State of the art review.
  Journal
Atherosclerosis 262:171-178 (2017)
DOI:10.1016/j.atherosclerosis.2017.05.001
Reference
  Authors
He Y, Ki H, Kim H, Kim K
  Title
delta-Catenin interacts with LEF-1 and negatively regulates its transcriptional activity.
  Journal
Cell Biol Int 39:954-61 (2015)
DOI:10.1002/cbin.10465
Reference
  Authors
Esaki N, Enomoto A, Takagishi M, Mizutani Y, Iida T, Ushida K, Shiraki Y, Mii S, Takahashi M
  Title
The Daple-CK1epsilon complex regulates Dvl2 phosphorylation and canonical Wnt signaling.
  Journal
Biochem Biophys Res Commun 532:406-413 (2020)
DOI:10.1016/j.bbrc.2020.08.066
Reference
  Authors
Yiew NKH, Chatterjee TK, Tang YL, Pellenberg R, Stansfield BK, Bagi Z, Fulton DJ, Stepp DW, Chen W, Patel V, Kamath VM, Litwin SE, Hui DY, Rudich SM, Kim HW, Weintraub NL
  Title
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesity.
  Journal
J Biol Chem 292:6312-6324 (2017)
DOI:10.1074/jbc.M116.758078
Related
pathway
nle04010  MAPK signaling pathway
nle04110  Cell cycle
nle04115  p53 signaling pathway
nle04120  Ubiquitin mediated proteolysis
nle04350  TGF-beta signaling pathway
nle04510  Focal adhesion
nle04520  Adherens junction
nle05010  Alzheimer disease
KO pathway
ko04310   
LinkDB

DBGET integrated database retrieval system